Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (881-890 of 1,298) with videos related to

Pageof 130
Sort By:
Plos One|July 24, 2018
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitorsGarrett W Rhyasen, Yi Yao, Jingwen Zhang, et al.
The Journal of Clinical Investigation|November 5, 2019
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosisXiaoyan Xu, Yumeng Wang, Kamalika Mojumdar, et al.
Cell Reports. Medicine|November 1, 2023
Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteinsDaniel J McGrail, Yang Li, Roger S Smith, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acidRenuka Gupte, Anjaih Siddam, Yan Lu, et al.
Cancer Discovery|June 13, 2015
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP InhibitorsJianfeng Shen, Yang Peng, Leizhen Wei, et al.
Cancer Discovery|July 19, 2022
Biomolecular Condensation: A New Phase in Cancer ResearchAnupam K Chakravarty, Daniel J McGrail, Thomas M Lozanoski, et al.
Plos One|November 21, 2012
Somatic mutations of PIK3R1 promote gliomagenesisSteven N Quayle, Jennifer Y Lee, Lydia W T Cheung, et al.
The Journal of Clinical Investigation|October 5, 2020
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumorsLulu Wang, Lin Yang, Chen Wang, et al.
Annals of Surgery|May 27, 2024
A Randomized Controlled Trial of the Implementation of BREASTChoice , a Multilevel Breast Reconstruction Decision Support Tool With Personalized Risk PredictionMary C Politi, Terence M Myckatyn, Krista Cooksey, et al.
Breast Cancer Research : BCR|August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBrian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.
Pageof 130

Showing results (881-890 of 1,298) with videos related to

Sort By:
Pageof 130
Plos One|July 24, 2018
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitorsGarrett W Rhyasen, Yi Yao, Jingwen Zhang, et al.
The Journal of Clinical Investigation|November 5, 2019
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosisXiaoyan Xu, Yumeng Wang, Kamalika Mojumdar, et al.
Cell Reports. Medicine|November 1, 2023
Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteinsDaniel J McGrail, Yang Li, Roger S Smith, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acidRenuka Gupte, Anjaih Siddam, Yan Lu, et al.
Cancer Discovery|June 13, 2015
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP InhibitorsJianfeng Shen, Yang Peng, Leizhen Wei, et al.
Cancer Discovery|July 19, 2022
Biomolecular Condensation: A New Phase in Cancer ResearchAnupam K Chakravarty, Daniel J McGrail, Thomas M Lozanoski, et al.
Plos One|November 21, 2012
Somatic mutations of PIK3R1 promote gliomagenesisSteven N Quayle, Jennifer Y Lee, Lydia W T Cheung, et al.
The Journal of Clinical Investigation|October 5, 2020
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumorsLulu Wang, Lin Yang, Chen Wang, et al.
Annals of Surgery|May 27, 2024
A Randomized Controlled Trial of the Implementation of BREASTChoice , a Multilevel Breast Reconstruction Decision Support Tool With Personalized Risk PredictionMary C Politi, Terence M Myckatyn, Krista Cooksey, et al.
Breast Cancer Research : BCR|August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBrian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.
Pageof 130